For researchers

Is your paper here?

2,661 papers hold this site up. Every variant and condition page names the research it was written from, and this is that list, gathered from the pages themselves. Search your name, your journal, or a PMID.

9 matches for Whirl-Carrillo M.

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, Moyer AM, Evans WE, Klein TE, Antillon-Klussmann FG, Caudle KE, Kato M

and 3 more — show all

Yeoh AEJ, Schmiegelow K, Yang JJ

Clinical pharmacology and therapeutics · 2019 · PMID 30447069

5 pages

rs1142345 rs116855232 Crohn's Disease Ulcerative Colitis Thiopurine Dosing (TPMT and NUDT15)

Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype

Gammal RS, Pirmohamed M, Somogyi AA, Morris SA, Formea CM, Elchynski AL, Oshikoya KA, McLeod HL, Haidar CE, Whirl-Carrillo M, Klein TE, Caudle KE

and 1 more — show all

Relling MV

Clinical pharmacology and therapeutics · 2023 · PMID 36049896

3 pages

rs1050828 rs1050829 G6PD Deficiency

Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype

McDermott JH, Wolf J, Hoshitsuki K, Huddart R, Caudle KE, Whirl-Carrillo M, Steyger PS, Smith RJH, Cody N, Rodriguez-Antona C, Klein TE, Newman WG

Clinical pharmacology and therapeutics · 2022 · PMID 34032273

2 pages

rs267606617 Aminoglycoside-Induced Hearing Loss

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

Gammal RS, Court MH, Haidar CE, Iwuchukwu OF, Gaur AH, Alvarellos M, Guillemette C, Lennox JL, Whirl-Carrillo M, Brummel SS, Ratain MJ, Klein TE

and 3 more — show all

Schackman BR, Caudle KE, Haas DW

Clinical Pharmacogenetics Implementation Consortium

Clinical pharmacology and therapeutics · 2016 · PMID 26417955

1 page

CCR5-Delta32 and HIV-1 Resistance

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update

Johnson JA, Caudle KE, Gong L, Whirl-Carrillo M, Stein CM, Scott SA, Lee MT, Gage BF, Kimmel SE, Perera MA, Anderson JL, Pirmohamed M

and 4 more — show all

Klein TE, Limdi NA, Cavallari LH, Wadelius M

Clinical pharmacology and therapeutics · 2017 · PMID 28198005

1 page

Warfarin Sensitivity and Anticoagulant Dose Variability

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Goetz MP, Sangkuhl K, Guchelaar HJ, Schwab M, Province M, Whirl-Carrillo M, Symmans WF, McLeod HL, Ratain MJ, Zembutsu H, Gaedigk A, van Schaik RH

and 3 more — show all

Ingle JN, Caudle KE, Klein TE

Clinical pharmacology and therapeutics · 2018 · PMID 29385237

1 page

Breast Cancer

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

Phillips EJ, Sukasem C, Whirl-Carrillo M, Müller DJ, Dunnenberger HM, Chantratita W, Goldspiel B, Chen YT, Carleton BC, George AL Jr, Mushiroda T, Klein T

and 2 more — show all

Gammal RS, Pirmohamed M

Clinical pharmacology and therapeutics · 2018 · PMID 29392710

1 page

Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy

Desta Z, Gammal RS, Gong L, Whirl-Carrillo M, Gaur AH, Sukasem C, Hockings J, Myers A, Swart M, Tyndale RF, Masimirembwa C, Iwuchukwu OF

and 5 more — show all

Chirwa S, Lennox J, Gaedigk A, Klein TE, Haas DW

Clinical pharmacology and therapeutics · 2019 · PMID 31006110

1 page

CCR5-Delta32 and HIV-1 Resistance

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update

Karnes JH, Rettie AE, Somogyi AA, Huddart R, Fohner AE, Formea CM, Ta Michael Lee M, Llerena A, Whirl-Carrillo M, Klein TE, Phillips EJ, Mintzer S

and 3 more — show all

Gaedigk A, Caudle KE, Callaghan JT

Clinical pharmacology and therapeutics · 2021 · PMID 32779747

1 page

Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Questions about this list

Why is my paper here? I never gave you permission.

Nothing of your paper is reproduced here. This page records that a MyGeneLog™ page cites your work, and links to the paper on PubMed — which is what a citation is. Your title and author list come from Europe PMC, the same public record a library catalogue uses.

Why are all the authors listed instead of "et al."?

Because a study that needed 622 people is a different kind of study from one that needed four, and "et al." erases that. Twelve names show and the rest are one click away. Everyone is searchable, including the 187th name on a consortium paper — that person exists and may be looking for it.

My name is misspelt, or the paper is wrong.

Tell us and it is fixed. Names come from the public record and initials are inconsistent across databases; where two people share a form of a name we cannot separate them, and we would rather be corrected than guess.

My paper is not here. Does that mean you rejected it?

No. This catalogue is assembled from what a small team could read, and it is thinnest outside European-ancestry cohorts. A paper is absent because nobody has got to it, not because it was assessed and turned down.

Which pages rest on a paper?

Each row lists them, up to six, and links to each one. The count beside a row is how many pages cite it in total.

How often does this change?

It is rebuilt from the pages every hour. A paper appears the moment a page starts resting on it and disappears if that page stops — there is no separate list to keep in step, because the citation lives on the page that makes the claim.